Abstracts are available online: Plenary, Oral & Poster Abstracts

Download the 15th ICID Final Program as pdf here.

Download program overview as pdf here.

• Funding Research in Low and Middle Income Countries: Strategies for Developing a Successful Grant Application
  L. Bethke (United Kingdom)
  15thICID_Bethke.pdf (519 kB)

• H. Wilde (Thailand)
• T. Hemachudha (Thailand)
  15thICID_Hemachudha_2.pdf (3.8 MB)
• S. Wacharapluesadee (Thailand)
  15thICID_Wacharapluesadee.pdf (1.2 MB)

• D. Gubler (Singapore)
  15thICID_Gubler.pdf (9.6 MB)

• Diagnostic Challenges and Interactive Case Histories
  P.R. Hsueh (Taiwan)
  15thICID_Hsueh_1.pdf (4.3 MB)
• Fluoroquinolones: A Role in CAP and TB
  R. Grossman (Canada)
  15thICID_Grossman.pdf (966 kB)
• Fluoroquinolones in TB: The Future
  S. Gillespie (United Kingdom)

• State of the Science: Antiretroviral Treatment for Prevention
  B. Hirschel (Switzerland)
  15thICID_Hirschel.pdf (4.4 MB)
• Treatment 2.0
  M. Kato (Vietnam)
  15thICID_Kato.pdf (2.1 MB)
• State of the Science - HIV Pre Exposure Prophylaxis (PrEP)
  S. Chariyalertsak (Thailand)
  15thICID_Chariyalertsak.pdf (4.9 MB)
• Implementing PrEP - Are We Ready?
  J. Ananworanich (Thailand)
  15thICID_Ananworanich.pdf (215 kB)

• Infectious Diseases Among Refugees in Beirut
  I. Beldjebel (Lebanon)
  15thICID_Beldjebel.pdf (1.1 MB)
• Infectious Diseases in Orphanages in South-East Asia
  J. Benca (Cambodia)
  15thICID_Benca.pdf (638 kB)
• Infections in the Homeless
  V. Krcmery (Slovakia)
  15thICID_Krcmery.pdf (1.7 MB)
• Infectious Diseases of Street Children in Nairobi
  L. Alumbasi Timona (Kenya)
  15thICID_Alumbasi Timona.pdf (935 kB)

• Global Infection Control: A  U.S. Perspective on Health Care Associated Infections
  R. Wenzel (USA)
  15thICID_Wenzel.pdf (5.1 MB)
• Infection Control to Curb Resistance in Asia
  W.H. Seto (China)
• Implementing Infection Control in Resource Limited Settings
  G. Mehta (India)
• Regional Differences Impacting Infection Control Practices
  B. Allegranzi (Switzerland)

• Introduction on the global dengue epidemiological burden
  T. Chotpitayasunondh (Thailand)
  15thICID_Chotpitayasunondh.pdf (3.1 MB)

• Economic impact of dengue in South East Asia

  L. Yee Sin (Singapore)
• Dengue vaccine late stage development update
  J. Lang (France)
• Potential impact of dengue vaccination: A modeling approach
  E. Massad (Brazil)

• Roadmap for successful dengue vaccine introduction
  R. Tapia-Conyer (Mexico)

• Role of media scanning and verification system as a supplemental tool to disease outbreak detection & reporting under integrated disease surveillance project (IDSP)-India
  R. Sharma (INDIA)
• From Taiwan’s experience to global prevention and control of pandemic influenza - surveillance, epidemiology and public health policies
  C.-C. King (TAIWAN, R.O.C.)
• Age-stratified transmission dynamic models to assess severity of influenza pandemics in real-time
  L. Ponnambalam (SINGAPORE)
• Geographic, gender, and age distribution of measles deaths in India: estimates from a nationally representative study of over 12000 child deaths
  S. Morris (CANADA)
• Virus-specific incidence rates of hospitalization for severe acute respiratory infections among children aged <5 years in rural Bangladesh, 2010
  S. Nasreen (BANGLADESH)
• The epidemiology of pneumonia in a birth cohort of children living on the Thai-Myanmar border
  C. Turner (THAILAND)
• Spatial and temporal dynamics of dengue in southern Vietnam
  K. Anders (VIETNAM)
• Dengue attack rate and proportion of asymptomatic infections in the Kampong Cham prospective community study, 2011: preliminary data
  S. LY (CAMBODIA)
• Surveillance and characterisation of influenza among patients with influenza-like illness in Bali, Indonesia
  J. Rudge (THAILAND)
• Travellers contribute largely to the epidemiology of influenza: a prospective study
  G. J. B. Sonder (NETHERLANDS)

Plenary Lecture
Killed Oral Cholera Vaccines: from Concept to Public Health Reality
Thursday, June 14, 2012, 14:30 - 15:15hrs

• J. Clemens (Republic of Korea)

• Pythium Insidiosum Infections: Clinical Presentations and Treatment
  B. Sathapatayavongs (Thailand)
  15thICID_Sathapatayavongs.pdf (1.3 MB)
• Penicillium marneffei Infections
  K. Supparatpinyo (Thailand)
  15thICID_Supparatpinyo.pdf (3.7 MB)
• Changing Epidemiology and Treatment Options in Invasive Candida Infections
  T. Gottlieb (Australia)
  15thICID_Gottlieb.pdf (718 kB)
  Cryptococcus Infection  in Immunocompetent Individuals
  G. Reid (USA)
  

• Urbanization
  L. Loutan (Switzerland)
  15thICID_Loutan.pdf (16.9 MB)
• Pilgrimages and Mass Migrations
  Z. Memish (Saudi Arabia)
• Changing Interfaces with Animals: Emerging Zoonoses
  R. Coker (Thailand)
  15thICID_Coker.pdf (1.6 MB)

• Neglected Tropical Diseases Targeted for Elimination in South-East Asia - Progress so Far
  A. P. Dash (India)
  15thICID_Dash.pdf (1.1 MB)
• Elimination of Lymphatic Filariasis in Bangladesh - Critical Issues
  I. Hafiz (Bangladesh)
• Schistosomiasis Control Program in China: Towards Elimination
  S.Z. Li (China)
  15thICID_Li.pdf (2.9 MB)
• NTD Programs in the Western Pacific Region- Challenges and Opportunities
  L.A. Tuan (Philippines)

• Welcome and Introduction
  L.M. Huang (Taiwan)
  
• Meningococcal Disease: A Public Health Concern
  L. Harrison (USA)
• Broadening Protection with a Conjugate Quadrivalent (ACWY) Meningococcal Vaccine
  T. Jadavji (Canada)
• An Innovative Step in the Global Fight Against Serogroup B Meningococcal Disease
  A. Finn (United Kingdom)
• Summary and Conclusion from the Session - A Call to Action
  L.M. Huang (Taiwan)

• Epidemiology and Natural Course of Chronic Viral hepatitis B in Asia
  S. Thongsawat (Thailand)
  15thICID_Thongsawat.pdf (2.5 MB)
• Updates on Early Diagnosis and Management of Hepatocellular Carcinoma in HBV
  P. Komolmit (Thailand)
  15thICID_Komolmit.pdf (2.5 MB)
• HBV-HEV Dual Infection and the Molecular Pathogenesis of Hepatitis E
  R.K. Ratho (India)

• Principles and Practice
  D. Lye (Singapore)
  15thICID_Lye_2.pdf (733 kB)
• Lessons from Practical Implementation
  L. Hsu (Singapore)

• J. Garza (Mexico)
  15thICID_Garza.pdf (2.4 MB)
• L. Wang (Australia)

• D. Pittet (Switzerland)
  15thICID_Pittet.pdf (7.1 MB)

• Overview of Carbapenemase Mediated Resistance
  G. Cornaglia (Italy)
  15thICID_Cornaglia.pdf (4.3 MB)
• Detection of Carbapenemase-mediated Resistance
  P. Nordmann (France)
  15thICID_Nordmann.pdf (2.7 MB)
• The Role of Antimicrobial Stewardship in Curbing Carbapenem Resistance
  D. Lye (Singapore)
  15thICID_Lye_1.pdf (663 kB)
• The Role of Infection Control in Curbing Carbapenem Resistance
  A. Apisarnthanarak (Thailand)
  15thICID_Apisarnthanarak_1.pdf (1.8 MB)

• Polio Eradication
  E. Vidor (France)
• The Evolution of Pertussis Vaccines and Vaccination Programs
  D. Greenberg (USA)
• Pentavalent & Hexavalent Combination Vaccines of Today & Tomorrow
  S. Madhi (South Africa)

• Hepatitis C: Asia-Pacific Perspective
  T. Piratvisuth (Thailand)
• Treatment of Hepatitis C in 2012
  J. Koirala (USA)
  15thICID_Koirala.pdf (1.9 MB)
• Management of Hepatitis C in HIV-Coinfected Patients
  J. Rockstroh (Germany)
• Epidemiology of Hepatitis C Virus- Genotypes 1 Through 6 in Asia and the world"
  Y. Poovorawan (Thailand)
  15thICID_Poovorawan.pdf (3 MB)

• Carriage of S. pneumoniae and Related Respiratory Pathogens Post PCV Implementation
  E. Sanders (Netherlands)
  15thICID_Sanders.pdf (2.7 MB)
• Density of Carriage - Can it Predict Pneumonia?
  K. Klugman (USA)
  15thICID_Klugman.pdf (2.5 MB)
• S. pneumoniae and Viruses: Do We Know Everything?
  M. Mina (USA)

• Typhoid Epidemiology
  L. Ochiai (Republic of Korea)
  15thICID_Ochiai.pdf (1.8 MB)
• Typhoid Diagnostics
  S. Baker (Vietnam)
• Typhoid Treatment and MDR Typhoid
  J. Farrar (Vietnam)
  15thICID_Farrar_1.pdf (2 MB)
• Typhoid Vaccine Landscape
  A. Pollard (United Kingdom)

• The last phase of dracunculiasis eradication in Ethiopia, 1994-2011
  G. E. Yembo (ETHIOPIA)
• Redox metabolism of Leishmania parasite: Ideal target for drug development against leishmaniasis
  A. Shukla (INDIA)
• Multiple mitochondrial introgression events and heteroplasmy in Trypanosoma cruzi revealed by maxicircle MLST and next generation sequencing
  L. Messenger (UNITED KINGDOM)
• Community level day-3 positive surveillance of Plasmodium falciparum malaria in Cambodia
  C. Say (CAMBODIA)
• Mapping drug-resistant malaria in western Cambodia through 28-day case follow-up
  K. Soy Ty (CAMBODIA)
• Strengthening surveillance to assess the burden of leishmaniasis in Afghanistan
  E. Vuolo (AFGHANISTAN)
• Potential adverse outcomes of maintenance intravenous fluid in adult dengue without plasma leakage: an observational cohort study
  A. Cook (SINGAPORE)
• Concurrent brucellosis and Q fever infection: a case control study in Bamyan Province, Afghanistan in 2011
  K.M.I. Saeed (AFGHANISTAN)
• Encephalitis syndrome: Look for autoimmune causes
  A. Saraya (THAILAND)
• Reducing risk of emerging infectious diseases in Bangladesh through ecohealth
  D. Hall (CANADA)

• C.L. Lai (China)
  15thICID_Lai.pdf (1.8 MB)

• Singapore
  L.Y. Hsu (Singapore)
  15thICID_Hsu.pdf (2.1 MB)
• Taiwan
  P.R. Hsueh (Taiwan)
  15thICID_Hsueh_2.pdf (3 MB)
• Japan
  K. Yanagihara (Japan)
• South Korea
  D.R. Chung (Republic of Korea)
  15thICID_Chung.pdf (3.6 MB)
• Thailand
  R. Chaiwarith (Thailand)
  15thICID_Chaiwarith.pdf (1.7 MB)

• Delivering HIV Treatment & Care in Resource Limited Settings - Therapeutic Mobile Units
  F.X. Mbopi Keou (Cameroon)
  15thICID_Mbopi Keou.pdf (1.6 MB)
• New Diagnostic Tools for Monitoring Antiretroviral Therapy in Resource Limited Settings
  S. Crowe (Australia)
  15thICID_Crowe.pdf (1.8 MB)
• Management of Antiretroviral-Therapy Failure in Resource-Limited Settings
  K. Ruxrungtham (Thailand)
• HIV Drug Resistance Testing in Asia - Is it Time?
  S. Sungkanuparph (Thailand)

• Emerging Drug Resistance
  A. Dondorp (Thailand)
  15thICID_Dondorp.pdf (2.8 MB)
• Progress Towards Effective Malaria Vaccination
  C. Ockenhouse (USA)
• A Future Without Malaria?
  Y. Yuthavong (Thailand)
• Update on Management of Severe Malaria
  S. Mishra (India)

• Novel Resources to Fund Health Enterprises and Develop New Drugs
  F. Waldvogel (Switzerland)
  15thICID_Waldvogel.pdf (499 kB)
• Facilitating Clinical Research for Global Health Needs
  J. Farrar (Vietnam)
  15thICID_Farrar_2.pdf (2.4 MB)
• Infectious Diseases Surveillance and Alert Systems
  L. Madoff (USA)
  15thICID_Madoff.pdf (2.2 MB)

• Human and Animal Epidemiology of Influenza in South-East Asia
  T. Chotpitayasunondh (Thailand)
• Clinical Features and Pathogenesis of H5N1 Influenza in Humans
  T.T. Hien (Vietnam)
  15thICID_Hien.pdf (927 kB)
• Newer Influenza Antivirals and Biotherapeutics
  F. Hayden (USA)
• Seasonal, Pandemic, and Inter-Pandemic Vaccines
  L. Jennings (New Zealand)
  15thICID_Jennings.pdf (1.8 MB)

• Viral pathogenicity requires a multipronged strategy to combat the innate immune response
  G. Moseley (AUSTRALIA)
• High mobility group box I protein (HMGB-I) as an early diagnostic biomarker of acute liver injury in patients with hepatitis E
  M. Majumdar (INDIA)
• RNAi therapeutics for the treatment of chronic hepatitis B virus infection
  D. Lewis (USA)
  
• CD4+CD25+ T regulatory cells, chronic liver disease and role in immunotherapy of HBV related hepatocellular cancer
  N. Trehanpati (INDIA)
• Ten year follow up of treatment of Hepatitis C in intravenous drug users
  J. Farley (CANADA)
• Epidemiological significance of non-glycosylated Asn residues found in the hemagglutinin protein of the H1N1 influenza virus from 1918 to 2012
  M. Cueno (JAPAN)
• Nucleic acid-based drugs against the highly pathogenic H5N1 avian influenza virus infection
  J. Wong (CANADA)
• SARS-Coronavirus ancestor's foot-prints in Thai bat colonies and the refuge theory: a phylogeography perspective
  M. Le Gouil (FRANCE)
• Outbreak of dengue fever in northeastern Kenya, 2011
  M. Obonyo (KENYA)
• First multicentre evaluation of serological and molecular diagnostic assays for Crimean-Congo hemorrhagic fever
  J. Vanhomwegen (FRANCE)
• Safety and immunogenicity of INV21, an inactivated vaccine candidate for the prevention of hand, foot and mouth disease caused by enterovirus 71
  P. Tambyah (SINGAPORE)

• A. Rudolph (USA)

• S. Lewin (Australia)
  15thICID_Lewin.pdf (2.5 MB)

• Elimination of Kala-azar: Where Do We Stand in 2011?
  S.K. Bhattacharya (India)
  15thICID_Bhattacharya.pdf (442 kB)
• Progress in Treatment of Kala-azar
  S. Rijal (Nepal)
  15thICID_Rijal.pdf (2.9 MB)
• Kala-azar Elimination - Monitoring and Evaluation
  M. Rahman (Bangladesh)
  15thICID_Rahman2.pdf (565 kB)

• K.B. Chua (Singapore)
• J. Laothamatas (Thailand)
  15thICID_Laothamatas.pdf (8.3 MB)
• T. Hemachudha (Thailand)
  15thICID_Hemachudha_1.pdf (5.5 MB)

• The Pre-Transplant Evaluation
  N. Smitasin (Singapore)
  15thICID_Smitasin.pdf (419 kB)
• Donor Derived Infections
  G. Reid (USA)
• State of the Art: Transplantation in HIV Infected Individuals
  M. Brito (USA)
• Common Respiratory Viral Infections
  L. Kaiser (Switzerland)
  15thICID_Kaiser.pdf (1.3 MB)

• Eradicating Polio
  J. John (India)
  15thICID_John.pdf (2.5 MB)
• Vaccination Programs in South-East Asia
  U. Thisyakom (Thailand)
  15thICID_Thisyakom.pdf (3.7 MB)
• Facing Antivaccine Movements: Myths and Facts About Adverse Events
  K. Powell (USA)
  15thICID_Powell.pdf (466 kB)

• Transmission Dynamics of MRSA in Asia
  B. Cooper (Thailand)
  15thICID_Cooper.pdf (2.8 MB)
• Developing Resistance to Drugs Against MRSA
  I. Gould (United Kingdom)
• Resistance to Agents for MRSA Decolonization and Its Clinical Implications
  A. Apisarnthanarak (Thailand)
  15thICID_Apisarnthanarak_2.pdf (2.9 MB)
• PK/PD Considerations When Treating MRSA
  T. Mazzei (Italy)
  15thICID_Mazzei.pdf (453 kB)

• S. Lawn (South Africa)
  15thICID_Lawn.pdf (6.1 MB)

• Acute Febrile Illness in Africa
  O. Mediannikov (Senegal)
  15thICID_Mediannikov.pdf (3.7 MB)
• Acute Febrile Illness: Epidemiology vs Clinical Judgment
  R. Premaratna (Sri Lanka)
  15thICID_Premaratna.pdf (4 MB)
• Laboratory Diagnosis of Acute Febrile Illness: Where are We Now?
  C.C. Chao (USA)
  15thICID_Chao.pdf (708 kB)
• Strategies for Diagnosis and Treatment of Acute Febrile Illness in Asia
  Y. Suputtamongkol (Thailand)
  15thICID_Suputtamongkol.pdf (3 MB)

• The Role of Coinfections in HIV Epidemic Trajectory and Positive Prevention
  R. Barnabas (USA)
  15thICID_Barnabas.pdf (631 kB)
• Hepatitis B Coinfection: Implications for Management
  A.  Avihingsanon (Thailand)
• HPV and HIV Coinfection
  N. Phanuphak (Thailand)
  15thICID_Phanuphak.pdf (737 kB)
• Syphilis and HIV: Problem and Prevention
  J.T. Lau (China)

• Innate Immune Recognition and Response to Pathogens
  S. Akira (Japan)
• Malaria and Innate Immunity
  D. Golenbock (USA)
  15thICID_Golenbock.pdf (3.6 MB)
• Stimulation of Macrophage Innate Immunity to Prevent Human Mycobacterial Disease
  O. Stendahl (Sweden)
  15thICID_Stendahl.pdf (1.9 MB)
• Relationship Between the Innate Immune System and the Acquired Immune System: Implications for Vaccine Development
  K. Rock (USA)

• Epidemiology, Clinical Manifestations, and Diagnostic Challenges of Pediatric TB
  C. Sreeramareddy (Malaysia)
  15thICID_Sreeramareddy.pdf (2.2 MB)
• Update on Laboratory Diagnosis of Pediatric TB: New and More Rapid Methods
  C. Mukhopadhyay (India)
• Programmatic Barriers, Current Treatment and Control Strategies for Pediatric TB
  M. Rahman (Bangladesh)
  15thICID_Rahman1.pdf (2.1 MB)
• Pitfall and Challenges in Clinical Management of Childhood TB
  K. Chokephaibulkit (Thailand)
  15thICID_Chokephaibulkit.pdf (1.5 MB)